gm-k562 cell vaccine
Vaccineexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2005 (NCT00301093)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gm-k562 cell vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00656123 | Phase 1 | Mar 1, 2008 | Johns Hopkins University, National Cancer Institute (NCI) |
| NCT00363649 | Phase 2 | Sep 1, 2006 | Johns Hopkins University, National Cancer Institute (NCI) |
| NCT00361296 | Early Phase 1 (Phase 1) | Aug 1, 2006 | Johns Hopkins University, National Cancer Institute (NCI) |
| NCT00301093 | Phase 1 | Sep 1, 2005 | Harvard University, National Cancer Institute (NCI) |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 4 | 0 | 2 | 2005 |
| Johns Hopkins University | Academic/Hospital | 3 | 3 | 2 | 2006 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2005 |
3 organizations
Page 1 / 1